The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes

Citations Over TimeTop 10% of 2017 papers

Abstract

Abstract Constitutive activation of the Wnt pathway/β-catenin signaling may be important in aldosterone-producing adenoma (APA). However, significant gaps remain in our understanding of the prevalence and clinical outcomes after adrenalectomy in APA patients harboring CTNNB1 mutations. The molecular expression of CYP11B2 and gonadal receptors in adenomas were also explored. Adenomas from 219 APA patients (95 men; 44.2%; aged 50.5 ± 11.9 years) showed a high rate of somatic mutations (n = 128, 58.4%). The majority of them harbored KCNJ5 mutations (n = 116, 52.9%); 8 patients (3.7%, 6 women) had CTNNB1 mutations. Patients with APAs harboring CTNNB1 mutations were older and had shorter duration of hypertension. After adrenalectomy, CTNNB1 mutation carriers had a higher possibility (87.5%) of residual hypertension than other APA patients. APAs harboring CTNNB1 mutations have heterogeneous staining of β-catenin and variable expression of gonadal receptors and both CYP11B1 and CYP11B2. This suggests that CTNNB1 mutations may be more related to tumorigenesis rather than excessive aldosterone production.

Related Papers

• → Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type 3(2016)29 cited
• → Deletion Hybrid Genes, due to Unequal Crossing Over between CYP11B1 (11 -Hydroxylase) and CYP11B2(Aldosterone Synthase) Cause Steroid 11 -Hydroxylase Deficiency and Congenital Adrenal Hyperplasia(2001)16 cited
• → Analysis of the Aldosterone Synthase (CYP11B2) and 11β-Hydroxylase (CYP11B1) Genes(2017)11 cited
• Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.(2005)
• → PET-tracers for differential diagnosis in primary hyperaldosteronism(2014)